ArticleBMC health services research2026
An analysis of a satellite oncological radiotherapy unit in the Canary Islands: a cost-minimisation study.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRadiotherapy access remains inequitable, particularly in geographically isolated regions such as island territories, where centralisation of services often requires long-distance travel for patients. This imposes substantial burdens on patients and their families, potentially resulting in treatment discontinuation or refusal. Decentralised service models, such as satellite radiotherapy units, have emerged as a promising strategy to bring care closer to underserved populations while preserving integration with centralised expertise. However, decentralisation also poses several challenges, including underutilisation, resource duplication, and higher operational costs. In 2022, a satellite radiotherapy unit was established in Fuerteventura (Canary Islands, Spain) to promote equitable access to cancer patients. The economic impact of this unit has not yet been evaluated.
objectiveTo compare the cost of delivering radiotherapy at the satellite unit of Fuerteventura with the cost at the reference centre in Gran Canaria for patients living in Fuerteventura.
methodsA cost-minimisation analysis was conducted from the perspective of the public health system using 2021 and 2023 data. Direct healthcare costs were estimated based on the annual costs of each facility, adjusted for treatment complexity and volume. Travel-related costs were derived from reimbursement data, including inter-island transport, accommodation and transfers for in-hospital patients. Costs per patient were compared, and the patient volume required for the satellite unit to generate cost-savings was calculated.
resultsIn 2023, 182 patients received radiotherapy at the Fuerteventura unit, compared to 2,501 at the reference centre in Gran Canaria. The average healthcare cost per patient was €6,855 at the satellite unit and €4,619 in Gran Canaria. However, average travel costs per patient dropped from €1,819 in 2021 (before the satellite unit) to €337 in 2023. Overall, total per-patient cost was €754 higher at the satellite unit in 2023. Our estimates suggest that the unit may generate cost-savings for the healthcare system once patient volume reaches 205 patients per year—a threshold already exceeded in 2024.
conclusionsThe satellite model demonstrates potential to deliver cost-comparable care as patient volumes increase. Moreover, improved proximity to treatment may offer additional access-related benefits, as suggested by previous literature, reinforcing the value of satellite models in promoting equitable access while maintaining high standards of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.